Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

medac uk - doxorubicin hydrochloride - solution for injection - 2mg/1ml

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

medac uk - doxorubicin hydrochloride - solution for injection - 2mg/1ml

Israel - inglês - Ministry of Health

taro international ltd, israel - doxorubicin hydrochloride - liposome concentrate for solution for infusion - doxorubicin hydrochloride 2 mg / 1 ml - doxorubicin - 1. first or second line therapy of aids related kaposis sarcoma in patients with low cd 4 counts and extensive mucocutaneous or visceral disease. 2. the treatment of patients with metastatic carcinoma of the ovary who are refractory to both paclitaxel and platinium-based chemotherapy regimens and who may also be refractory to topotecan. refractory is defined as a patient having progressive disease while on treatment or within 6 months of completing treatment. 3. as monotherapy for patients with metastatic breast cancer where there is an increased cardiac risk. 4. in combination with bortezomib for the treatment of progressive multiplemyeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.

Israel - inglês - Ministry of Health

j-c health care ltd - doxorubicin hydrochloride - liposome concentrate for solution for infusion - doxorubicin hydrochloride 2.0 mg/ml - doxorubicin - first or second line therapy of aids related kaposis sarcoma in patients with low cd 4 counts and extensive mucocutaneous or visceral disease the treatment of patients with metastatic carcinoma of the ovary who are refractory to both paclitaxel and platinium-based chemotherapy regimens and who may also be refractory to topotecan. refractory is defined as a patient having progressive disease while on treatment or within 6 months of completing treatmnt. as monotherapy for patients with metastatic breast cancer where there is an increased cardiac risk. in combination with bortezomib for the treatment of progressive multiplemyeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.

Armênia - inglês - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

ebewe pharma ges. m.b.h. nfg. kg - doxorubicin (doxorubicin hydrochloride) - concentrate for solution for infusion - 2mg/ml

Armênia - inglês - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

ebewe pharma ges. m.b.h. nfg. kg - doxorubicin (doxorubicin hydrochloride) - concentrate for solution for infusion - 2mg/ml

Cingapura - inglês - HSA (Health Sciences Authority)

accord healthcare private limited - doxorubicin hydrochloride - infusion, solution concentrate - doxorubicin hydrochloride 2 mg/ml

Jordânia - inglês - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية الصباغ - sabbagh drug store - doxorubicin hcl 10 mg/5ml - 10 mg/5ml

Jordânia - inglês - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية الصباغ - sabbagh drug store - doxorubicin hcl 50 mg/25ml - 50 mg/25ml

Armênia - inglês - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

ebewe pharma ges. m.b.h. nfg. kg - doxorubicin (doxorubicin hydrochloride) - concentrate for solution for infusion - 2mg/ml